Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

155953

	registered interest
	date	17/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will set targets and goals for speeding up the use of off-patent drugs outside their licensed indications, where evidence supports that use.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	214424
	answer	answer is ministerial correction date of answer 24/11/2014 answer text <p>We have no plans to set such targets or goals.</p><p> </p><p> </p><p> </p><p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>We are in the process of setting up a round-table discussion with key stakeholders, including NHS England and the National Institute for Health and Care Excellence to explore opportunities for supporting appropriate use of off-label drugs outside their licensed indications where the evidence supports this.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/11/2014 17:35:43 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

419533

	registered interest
	date	17/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Urinary System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many catheter associated urinary tract infection related deaths there were in the last three years.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	10618
	answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>This information is not available in the format requested.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 10:57:21 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

419535

	registered interest
	date	17/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Urinary System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people were admitted to hospital as an emergency case with acute retention of urine due to a blocked Foley catheter in the last three years.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	10620
	answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>The requested information is not available centrally as Hospital Episode Statistics cannot identify blocked catheters or the type of catheter in use.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 10:58:44 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

178540

	registered interest
	date	09/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects to publish the results of the consultation for the NHS England Research and Development Strategy.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	223768
	answer	answer is ministerial correction date of answer 24/02/2015 answer text <p>The consultation for the NHS England Research and Development Strategy closed in December 2013. NHS England subsequently decided not to publish the results of the consultation at that time, but instead to use the findings to inform a new piece of work which would be developed with the Department which will describe NHS England’s role in promoting and taking account of research in the new healthcare system.</p><p> </p><p> </p><p> </p><p>NHS England is working with the Department to agree a revised approach.</p><p> </p><p> </p><p> </p><p>Delivery of NHS England’s research objective was discussed at the accountability meeting on 14 October 2014. The minutes of this meeting are available at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/02/2015 16:49:23 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

93569

	registered interest
	date	15/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he plans to take to protect the future of local breast network groups should his Department's proposal for discontinuing the National Cancer Peer Review programme from 2015 go ahead.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	210723
	answer	answer is ministerial correction date of answer 22/10/2014 answer text <p>The National Cancer Peer Review (NCPR) programme is currently under review by NHS England and a number of options are being considered. The provision of site specific networks, such as those for breast cancer, is written into the national cancer peer review requirements, therefore the future of local breast network groups will be decided as part of the review of the NCPR programme. As yet however, no decision has been made.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 210989 question first answered 22/10/2014 15:15:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

78022

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Respiratory System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps (a) his Department and (b) NHS England plan to take to reduce premature mortality from respiratory disease.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	205718
	answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>The NHS Outcomes Framework 2014-15 sets out the Department’s priority areas for the National Health Service and includes reducing deaths from respiratory disease as a key indicator. In addition to this, the Mandate sets out the requirements for NHS England to improve outcomes in a range of areas, including preventing premature deaths from the biggest killers (including respiratory) and supporting people with long term physical and mental health conditions.</p><p> </p><p><em>Living Well for Longer: National Support for Local Action to Reduce Premature Mortality</em>, launched in April, sets out what the health and care system will do to achieve the Government’s ambition to be amongst the best in Europe at reducing levels of premature mortality. It brings together in one place the national actions taken by the Department of Health and wider Government, NHS England and Public Health England, in prevention, early diagnosis and treatment, focusing on the five big killers, including lung disease, and shows how they will support local leadership and interventions.</p><p> </p><p>The Department has supported a number of initiatives to help improve outcomes for people with respiratory disease. In July 2011, it published an outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in England, which sets out six high-level objectives to improve outcomes in these areas through high quality prevention, detection, treatment and care services. The Department has also supported the publication of a good practice guides on services for adults with asthma, which was published in 2012.</p><p> </p><p>The National Institute for Health and Care Excellence has published Quality Standards for COPD and for asthma setting out the markers of high-quality, cost-effective care and the implementation of these will also raise the standard of care people with these conditions receive.</p><p> </p><p>The Department has collaborated with the National Review of Asthma Deaths which is examined the circumstances surrounding deaths from asthma from 1 February 2012 to 30 January 2013 and reported on its findings in May of this year. Lessons learnt about the factors that contribute to asthma deaths will inform the NHS about what constitutes good care, and encourage the development of appropriate services for people with asthma.</p><p> </p><p>Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 14:13:24 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

174759

	registered interest
	date	20/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Bile Duct Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research his Department has commissioned into cholangiocarcinoma.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	221396
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>The Department has not commissioned any research relating specifically to cholangiocarcinoma. The National Institute for Health Research Imperial Biomedical Research Centre has a £3.6 million gastroenterology and hepatology research theme (2012-17). This includes research on cholangiocarcinoma biomarkers and imaging.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/01/2015 12:35:01 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

226307

	registered interest
	date	10/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, on which dates since 24 November 2014 he has discussed with NHS England its revised approach to promoting and taking account of research in the new healthcare system; and what the content of those discussions was.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	227007
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 227008 question first answered 17/03/2015 16:19:17 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

226308

	registered interest
	date	10/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, when NHS England plans to publish its revised approach to promoting and taking account of research in the new healthcare system; and what plans NHS England has to hold a formal consultation on that revised approach.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	227008
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 227007 question first answered 17/03/2015 16:19:16 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

433989

	registered interest
	date	03/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of multiple myeloma and the risks presented by late diagnosis of acute myeloid leukaemia.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	18669
	answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>Public Health England’s ‘Be Clear on Cancer’ campaigns do not currently include multiple myeloma.</p><br /><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise.</p><br /><p>We appreciate that this means that there are a number of cancers, besides Myeloid Leukaemia, that are not covered by ‘Be Clear on Cancer’ specifically. Given this, Public Health England is looking at developing an approach to raise awareness of generic symptoms that can indicate a wider number of cancers and the need to visit the doctor promptly with these symptoms. This work is currently in development, with the help of a number of experts, including clinicians and charities.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 11:47:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith